Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 63 Carcinoma, Non-Small-Cell Lung 60 Rectal Neoplasms 44 Glioblastoma 42 Stomach Neoplasms 37 Esophageal Neoplasms 33 Brain Neoplasms 33 Squamous Cell Carcinoma of Head and Neck 31 Colorectal Neoplasms 29 Pancreatic Neoplasms 26 Lung Neoplasms 24 Neoplasms 23 Glioma 23 Astrocytoma 22 Neoplasm Metastasis 21 Head and Neck Neoplasms 19 Sarcoma 17 Gliosarcoma 15 Esophageal Squamous Cell Carcinoma 15 Central Nervous System Neoplasms 15 Ovarian Neoplasms 14 Oligodendroglioma 13 Melanoma 13 Colonic Neoplasms 12 Adenocarcinoma Of Esophagus 12 Urinary Bladder Neoplasms 11 Prostatic Neoplasms 11 Carcinoma, Hepatocellular 11 Oropharyngeal Neoplasms 9 Carcinoma, Ovarian Epithelial 9

Interventions

Diathermy 20 Radiotherapy 10 Cisplatin 5 Fluorouracil 4 Drug Therapy 4 Radiation 3 Melphalan 3 Immune Checkpoint Inhibitors 3 Cytoreduction Surgical Procedures 3 Brachytherapy 3 tislelizumab 2 Solutions 2 Immunotherapy 2 Hyperthermia, Induced 2 Hydrogen Peroxide 2 Doxorubicin 2 Conization 2 Capecitabine 2 spartalizumab 1 sodium thiosulfate 1 anlotinib 1 Temozolomide 1 Surgical Procedures, Operative 1 Saline Solution 1 Radiation Dose Hypofractionation 1 Paclitaxel 1 Oxaliplatin 1 Mitomycin 1 Leucovorin 1 Laser Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperthermia × Surgical Procedures, Operative × Clear all

NCT06835049 2025-12-30

TNT-HYPE

Swiss Cancer Institute

Phase 2 Recruiting

Hyperthermia, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡